Today, CLSA applauded the U.S. House passage of H.R. 184, the Protect Medical Innovation Act, which permanently repeals the job and innovation hindering 2.3% medical device excise tax levied on medical technology companies.
CLSA is proud that hundreds of our innovative member companies call the Bay Area home, and we look forward to working with Mayor-elect London Breed and her Administration to advance thoughtful policies that will grow and ensure the vibrancy of San Francisco’s treasured life sciences ecosystem.
2018 – 2019 state budget includes $30 million for Precision Medicine Research
Newly introduced legislation bridges Medicare patient access gaps and modernizes policies to allow coverage of medical technologies approved through FDA’s expedited review process
Report shows that the life science industry continues to be a strong job engine for California; over 85% of companies surveyed indicate plans to add technical employees in the next year, particularly in R&D, Quality and Regulatory Affairs/Compliance.
California Life Sciences Association (CLSA) today announced a new Chair and the addition of a new member to its Board of Directors. William J. Newell, Chief Executive Officer of Sutro Biopharma, Inc., transitioned from Vice Chair to Chair of the Board. Jared L. Watkin, Senior Vice President, Diabetes Care, Abbott, has joined the Board of Directors. In addition, Melinda Richter, Global Head, Johnson & Johnson Innovation, JLABS, formerly CLSA’s Treasurer, was appointed as the new Vice Chair of the organization.
Bipartisan Legislators Named 2018 Visionary Award Recipients for Promoting Policies that Advance Biomedical Innovation at CLSA’s Annual Washington, D.C. Program
CLSA, the trade association representing California’s life sciences sector, today announced the opening of an expanded office and events center in San Francisco, which is home to many of the top life sciences companies in the state.
CLSI today named Presentation High School Sophomore Shloka Janapaty of San Jose, CA as the winner of CLSI’s 2018 Amgen Bay Area BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research and innovation in the biotechnology field.
OCTANe, Orange County’s life sciences and technology accelerator and California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, today announced the Life Sciences Growth Accelerator Program – a unique dual membership program designed to address the specific growth challenges of emerging life sciences companies.